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Abstract
Background: Following WHO recommendations, Morocco adopted in 1995 the universal salt iodization (USI) as
a strategy to prevent and control iodine deficiency disorders. In 2009, the standard salt iodine concentration was
adjusted to 15–40 mg/kg. The success of USI for the control of iodine deficiency disorders requires an evaluation
of iodine concentration in salt prior to assessing the iodine nutritional status of a population.
Methods: In our study we refer to the anterior studies that were made in Morocco in 1993 and 1998. 178 salt
samples from households were tested for iodine using spot-testing kits. The iodometric titration method was used
to analyze accurately the concentration of iodine in the 178 household salt samples. An empiric polling method
was adopted, using a non-probability sampling method; across the different twelve regions in the country.
Results: The median and interquartile range iodine concentration in salt was 2.9 mg/kg (IQR: 2.4-3.7). The results
show that only 25 % of households use iodized salt. The recommended iodine concentration in salt of 15–40 mg/kg
was met only in 4.5 % of salt samples. The bulk salt is used by 8 % of households. All samples of this bulk salt were
found in rural areas. According to nonparametric appropriate tests used, there is no significant difference in iodine
concentrations between regions, between urban and rural areas and between packaged and bulk salt.
Conclusions: Two decades since introducing legislation on Universal Salt Iodization, our survey shows that generalization
of iodized salt is far from being reached. In 2015, only a quarter of Moroccan households use the iodized salt and only 4.
5 % of salt is in conformity with regulations. The use of bulk salt by households in rural areas constitutes a major obstacle
to the success of USI. The National Iodine Deficiency Disorders Control Program can only be achieved if an internal
follow-up and a control of external quality of program is put in place.
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Background
Iodine is a trace element present in human body at very
low quantities (10-15 mg). The only known role of
iodine in the human body is to constitute an essential
element in the synthesis of the thyroid hormones:
Thyroxin and Triiodothyronine (T3) [1].
In case of iodine deficiency, anomalies in thyroid func-
tion and goiter may occur; they vary according to the
relevance of iodine deficiency and age of subjects. These
sets of complications are known under the term of
Iodine Deficiency Disorders (IDD) [2].
Iodine deficiency holds a notorious place among the
micronutrient deficiencies which now pose a major
worldwide public health problem as it is the leading
cause of both thyroid and brain abnormalities in children
[3]. It is especially the first cause of thyroid disorders and
cerebral abnormalities in children. So, it leads to a slowing
of all metabolic functions and the psychomotor alteration.
It is the first cause of avoidable mental retardation in
worldwide [3].
Iodine deficiency disorders stands as a major obstacle
to economic development, due to the severity of irre-
versible neurological damage caused, it constitutes a
factor of social and economic exclusion [4, 5]. It is esti-
mated that in the general population, 2 billion people
have insufficient iodine intake which 31.5 % of school-age
children [6]. 38 million children born every year at risk of
brain damage because of iodine deficiency [7]. For the
elimination of iodine deficiency, WHO recommended
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Universal Salt Iodization [8], this includes how should
be used by all members of the population after 1 year
of age [9], which corresponds to an intake of < 5 g of
salt per day according to WHO recommendations on
sodium intake [10].
In India, the national average of self reported con-
sumption is 76.1 %, but only 51.1 % of Indians consume
adequately iodized salt 2005–2006 [11].
Morocco is considered as a moderate iodine deficiency
area. A survey in 1993 found that 63 % of children aged
6 to 12 years had urinary iodine less than normal
(<100 μg/L) and 22 % had a goiter [12]. Following WHO
recommendations, Morocco has adopted the universal
salt iodization strategy, in order to prevent and control
iodine deficiency disorders. Thus mandatory iodization
of table salt at 80 ± 10 mg of iodine/kg was introduced
in 1995 and subsequently adjusted to a level of 15–
40 mg of iodine/kg in 2009 [13]. Numerous studies have
been conducted to evaluate the iodine status in many
parts of Morocco [14–16].
To assess the success of Moroccan salt iodization pro-
gram, it is critical to control iodine concentration and
iodized salt coverage, which must be done before check-
ing the iodine nutritional status of the population [17].
Methods
Sample design
The study is a cross-sectional study; it covered all of the
12 Moroccan regions according to the administrative
division of February 2015. For sampling, we adopted the
empirical method of non-probability sampling across the
different regions. The convenience sampling was used
taking into account results of two previous studies with
similar objective where the rate of iodized salt was 9.8 %
and 15 % respectively [16, 18].
The sample size is calculated using the non-probability
sampling with 1.96 for a confidence level of 0.95 and
absolute error risk of 5 %. According to data above the
minimum sample size to be considered is 167.
Data collection
To reach the different 12 regions of Morocco, we have
chosen a number of pharmacy students, friends, ac-
quaintances and family members to which we explained
our study, and who were willing to bring us salt samples
used in their households or households of their parents.
Samples were collected during the period October 13,
2014 to March 30, 2015. The samples were coded and
stored at room temperature and protected from light
and moisture until the time of analysis. Sampling sheet
was filled in order to identify the address of the house-
hold, province, urban or rural areas, the type of salt
(packaging salt or bulk salt sold in traditional markets)
(Fig. 1) and the information mentioned on packets of
salt (Labeling iodized salt; Logo representative of iodized
salt; mentioning quantity of iodine added; mentioning
having sanitary authorization; mentioning having ONSSA
authorization; Date of manufacture/expiry; Address of
the company).
All the samples were analyzed by the same person
using the spot testing kits (MBI KITS International how
is provided by the management of Epidemiology and the
fight against non-transmissible diseases) [19] and iodo-
metric titration procedure [8, 20] in the Laboratory of
Medicinal Chemistry, Faculty of Medicine and Pharmacy
of Rabat.
Validation of spot-testing kits to determine iodine content
in salt
The spot-testing kit used to determine the percentage of
salt samples with iodine concentration above and below
15 ppm (mg/kg of salt) [19, 21]. It gives a qualitative es-
timation of the iodine content. Salt samples are classified
as iodized or non-iodized. Depending on the intensity of
the color obtained, the test gives an indication of the
level of iodine in the salt. If the test showed “no iodine”
on the first testing, the check solution was added again.
This was required to neutralize the presence of alkali in
salt and to acidify the salt sample. If the test showed no
iodine when tested for a second time, this was taken as
the negative test result [19].
Measurement of iodine concentration in salt by
iodometric titration procedure
Iodometric titration consists of a preparation of reagents
followed by two analytical steps. In these two steps, the
free iodine is released from salt and the free iodine is
then titrated with thiosulfate using starch as an external
indicator. The results are expressed as milligram of iodine
per kilogram of salt (mg/kg) [20].
Fig. 1 Bulk salt for retail sale at traditional market in Marrakech-Safi
region
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Data analysis
Basic descriptive statistics were calculated, including
frequencies, proportions, means, and medians. For Cat-
egorical data, the percentages and number of samples in
each category were presented. Iodine concentration with
skewed distribution are expressed as median and inter-
quartile range (IQR); Mann Whitney and Kruskal-Wallis
tests were used for comparing 2 or more groups, re-
spectively. Differences were considered significant when
P < 0.05. All statistical analyses were carried out using
SPSS 13.0 for Windows (SPSS, Inc., Chicago, IL, USA).
Results
A total of 178 salt samples were collected from different
regions of the country, where 92 % (n = 164) were pack-
aged salt in which 6 salt samples were from Spanish
companies, and 8 % (n = 14) were bulk salt. The number
of samples collected from urban and rural areas respect-
ively 134 and 44.
All salt samples commercialized by Moroccan com-
panies are labeled "iodized salt" and bearing the logo
representative of iodized salt, but 72 % did indicate the
adequate level of iodine "30 mg/kg". Two samples from
two different companies of 53 identified (3.8 %) men-
tioned the authorization number of National Food Safety
Office (ONSSA: Office National de Sécurité Sanitaire
des produits Alimentaires). The date of manufacture/ex-
piry is mentioned in 8 samples out of 164 (4.9 %).
The results of qualitative analysis with the iodine test
kit showed that 25 % (45/178) of samples are positive
and 75 % (133/178) negative. Besides, 28 % (38/134) of
salt commercialized in urban areas is iodized versus
16 % (7/44) in rural areas.
The median iodine concentration of 178 household salt
samples was 2.9 mg/kg (IQR: 2.4-3.7). According to
Kruskal-Wallis test, there is no significant difference in iod-
ine concentrations between regions (P = 0.113) (Table 1).
For samples identified as positive in the qualitative
test, the median iodine concentration was 5.8 mg/kg
(IQR: 4.2-9.3). For negative samples the median iodine
concentration was 2.6 mg/kg (IQR: 2.1-3.4).
For all salt samples, only 4.5 % are considered compli-
ant with legislation (15–40 mg/kg) and the median iod-
ine concentration of these samples was 17.8 mg/kg
(IQR: 16.4-21.7) (Table 2).
Lower median iodine concentration was obtained for
salt samples from rural areas compared to that from
urban areas, 2.6 mg/kg (IQR: 1.9-3.4) and 2.9 mg/kg
(IQR: 2.4-3.7), respectively, but there were no statisti-
cally significant difference (P = 0.148) (Table 3).
All bulk salts (n = 14) are from rural areas, none of was
found positive by kit-test. The median iodine concentration
in packaged salt is slightly higher than bulk salt, 2.9 mg/kg
(IQR: 2.4-3.7) versus 2.5 mg/kg (IQR: 1.5-3.4), but there
were no statistically significant difference (P = 0.105)
(Table 4).
Discussion
In the present study, we will evaluate the actual state of
salt covertures in Morocco.
Due to constraints of time and resources, we opted for
the empirical method of non-probability sampling across
the different regions, urban and rural areas.
Table 1 Distribution of median and interquartiles ranges of iodine concentration of household salt collected in 12 Moroccan regions
Region Population
households*
Population** Number of analyzed
salt samples




Region 1: Tanger-Tétouan-Al Hoceima 799 124 3 556 729 16 2 4.7 (3.2–14.5)*
Region 2: L'Oriental 494 530 2 314 346 10 2 2.6 (1.9–3.4)
Region 3: Fès-Meknès 919 497 4 236 892 41 4 2.9 (2.4–3.4)
Region 4: Rabat-Salé-Kénitra 1 015 107 4 580 866 42 4 2.8 (2.1–3.8)
Region 5: Béni Mellal-Khénifra 520 174 2 520 776 4 1 3.6 (2.8–6.5)
Region 6: Grand Casablanca-Settat 1 559 404 6 861 739 18 1 2.5 (2.0–3.3)
Region 7: Marrakech-Safi 928 120 4 520 569 13 1 2.9 (1.8–3.3)
Region 8: Drâa-Tafilalet 277 998 1 635 008 12 4 2.8 (2.4–3.6)
Region 9: Sous-Massa 601 511 2 676 847 11 2 2.4 (2.4–3.2)
Region 10: Guelmim-Oued Noun 90 202 433 757 7 8 2.6 (2.4–3.7)
Region 11: Laâyoune-Sakia El Hamra 78 754 367 758 3 4 4.2 (2.6–4.2)
Region 12: Dakhla-Oued Eddahab 29 385 142 955 1 3 2.9 (2.9–2.9)
Total 7 313 806 33 848 242 178 2 2.9 (2.4–3.7)
*P value = 0.113
**The number of households and population according to the census of the population of Morocco in September 2014. Decree No. 2-15-234 of 19 mars2015
published in the Official Bulletin No. 6358 of May 7, 2015. http://81.192.52.100/BO/fr/2015/BO_6358_Fr.pdf
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According to law act n°28–07 of the safety of food
products legislation published on 11thFebruary 2010,
ONSSA became the agency in charge of controlling and
monitoring of iodized salt for food. It delivers sanitary
authorization for new salt producers, according to a set
of specifications before placing to the market. According
to our results, only 3.8 % of companies marketing io-
dized salt have a sanitary authorization. The date of
manufacture/expiry is mentioned only in 8 samples out
of 164, although it is required by the standards.
None of samples marketed by Spanish companies indi-
cates the level of iodine contained, although according
to the regulations, all salts marketed on Moroccan terri-
tory must indicate on the packaging "iodized salt" and its
concentration. From these results regarding the labeling
of salt for food, we note that the producers and the con-
ditions of salt do not meet regulatory requirements. The
same thing goes for imported salt or illegally imported
salt to Morocco; it does not meet the standards imposed
by the law. This represents a real obstacle to the USI.
Analyses of iodine concentration in salt, show that a
quarter of households consume iodized salt, which is
an improvement compared to a study conducted at
Kenitra-Rabat in 1998, where less than of one tenth
of salt was iodized [16] and also in relation to the study
conducted in the province of Larache in 2003, where less
than of one sixth of salt was iodized [18]. Our results con-
firm the WHO data that rank Morocco among countries
where iodized salt consumption is less than 35 % [22].
However, less than one twentieth was properly iodized
(15–40 mg/kg).
The proportion of iodized salt is higher in urban
areas than in rural areas. This difference is partially
explained by the use of bulk salt in rural areas. A non-
negligible proportion of the samples collected come
from bulk salt purchased at retail. This bulk salt which
in addition is non-iodized was used by almost a third of
rural households.
According to tests used in data analysis, there are no
significant differences in iodine concentrations between
regions, between urban and rural areas and between
packaged and bulk salt.
This shows that Morocco is still far from reaching the
goal of broad coverage of iodized salt. This should draw
the attention of public health authorities about the pro-
gress of the USI strategy implementation, especially when
this is about to celebrate its 20th anniversary on 2015.
One of the lessons learned from countries that have
managed to eliminate or substantially reduce IDD is the
awareness of the key role that continuous monitoring of
the quality of salt and monitoring population iodine status
in the effectiveness of iodization programs. Proper moni-
toring would all for better adjustment of intervention and
assessment of impact. As they allow you to adjust the
intervention and assess its impact.
However, few are the countries that have a reliable
surveillance system [4].
The National Iodine Deficiency Disorders Control Pro-
gram can achieve its objectives if an internal monitoring
and external quality control program is put into place as
well as planning additional operational strategies like.
Governmental and salt producers must work in partner-
ship and help small producers to gather in cooperatives.
Moreover, ensuring the availability of potassium iodate
and test-kits and putting at the disposal of salt pro-
ducers. The control and monitoring of dietary salt
should be strengthened to prohibit the sale of bulk salt
in traditional markets and rural areas. Health authorities
need to adopt a different strategy for people who have
no access to iodized salt such as iodized oil, especially
in the most affected areas where the prevalence and
severity of IDD is highly amounted and to regularly
monitor iodine intake in the population, using an assay
of urinary iodine.
Conclusion
Since 1995 Morocco has adopted a National Iodine
Deficiency Disorders Control Program to fight against
Table 2 Proportion of Households salt samples and their
medians and interquartiles ranges of iodine concentration
according to iodine concentration intervals mg/kg
recommended by the order [13]
Iodine concentration intervals mg/kg
<15 mg/kg 15–40 mg/kg
Number and (%) of Households
salt samples
170 (95.5 %) 8 (4.5 %)
Median (IQR) iodine concentration
in mg/kg
2.9 (2.4–3.4) 17.8 (16.4–21.7)
Table 3 Sample sizes and medians and interquartiles ranges of
iodine concentration in household salt collected from urban
and rural areas
Origin of salt sample Sample size Median (IQR) iodine
concentration, in mg/kg
P value
Urban 134 (75 %) 2.9 (2.4–3.7) 0.148
Rural 44 (25 %) 2.6 (1.9–3.4)
All areas 178 (100 %) 2.9 (2.4–3.7)
Table 4 Sample sizes and medians and interquartiles ranges of
iodine concentration in packaged and bulk household salt
Type of salt sample Sample size Median (IQR) iodine
concentration in mg/kg
P value
Packaged salt 164 (92 %) 2.9 (2.4–3.7) 0.105
Bulk salt 14 (8 %) 2.5 (1.5–3.4)
All salt 178 (100 %) 2.9 (2.4–3.7)
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IDD by introducing iodized salt and enacting legislation
and standards to ensure the sustainability of the program.
20 years after implementation of the USI program, our
study shows that the goal of a widespread use of iodized
salt is still far from being achieved. In 2015, 25 % of
Moroccan households use iodized salt, but the proportion
of iodized salt conforming to the regulation standards is
only 4.5 %; with a median iodine concentration of
17.8 mg/kg (IQR: 16.4-21.7). The salt commercialized by
foreign companies does not meet the Moroccan stan-
dards, which represents a risk to the health of the popula-
tion. On the other hand, the use of bulk salt by 8 % of
households is a major obstacle to the USI. Effective sur-
veillance systems should include monitoring of iodine
content of salt at industrial, retail and household levels to
ensure that iodization program is safe and effective.
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